The evolution of hospital mortality from acute myocardial infarction during last 15 years. Impact of reperfusion therapy;Evolución de la mortalidad hospitalaria por infarto agudo de miocardio durante los últimos 15 años. Influencia de los tratamientos de reperfusión

Revista Espanola de Cardiologia

Volumn 52, Issue 8, 1999, Pages 547-555

  Errazti, Ildefonso Echanove ^a   Rami, José Antonio Velasco ^a   Soriano, Francisco Ridocci ^a   Domingo, Francisco Pomar ^a   Herrero, Vicente Vilar ^a   Alzamora, Nieves Martínez ^a   Serrano, Rafael Payá ^a   García, Andres Carrión ^a   Fernández, Felipe Atienza ^a   Viguer, Teresa Castelló ^a   Esteban, Esther Esteban ^a   Ortiz, Carmen Fabra ^a   Boscá, Leandro Pérez ^a   Domingo, Enrique Peris ^a   Hernández, Juan Antonio Rodríguez ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MORTALITY; SPAIN;

AGED; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; SPAIN; THROMBOLYTIC THERAPY;

EID: 0004937273     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(99)74970-5     Document Type: Article

References (32)

1. De Vreede JJM, Gorgels APM, Verstraaten GMP, Vermeer F, Dassen WRM, Wellens HJJ. Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis. J Am Coll Cardiol 1991; 18: 698-706.
2. Fibrinolytic Therapy Triallist Collaborative Group. Indications for fibrinolytic therapy in suspected myocardial infarction: collaboratory overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients. Lancet 1994; 343: 311-322.
3. Hennekens CH, Albert CM, Godfried S, Gaziano JM, Buring JE. Drug therapy: adjunctive drug therapy of acute myocardial infarction-Evidence from clinical trials. N Engl J Med 1996; 335: 1.660-1.667.
4. Naylor C, Chen E. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: the Ontario experience. J Am Coll Cardiol 1994; 24: 1.431-1.438.
5. Dellborg M, Eriksson P, Riha M, Swedwerg K. Declining hospital mortality in acute myocardial infarction. Eur Heart J 1994; 1: 5-9.
6. Gheorghiade M, Ruzumna P, Borzak S, Havstad S, Ali A, Goldstein S. Declining in the rate of hospital mortality from acute myocardial infarction: impact of changing management strategies. Am Heart J 1996; 131: 250-256.
7. Klein HH, Hengstenberg C, Peuckert M, Jurgensen R. Comparison of death rates from acute myocardial infarction in a single hospital in two different periods (1977-1978 versus 1988-1988). Am J Cardiol 1993; 71: 518-523.
8. Widdershoven JW, Gorgels APM, Vermeer F, Dijkman LW, Verstraaten GM. Dassen WR. Changing characteristics and inhospital outcome in patients admitted with acute myocardial infarction. Observations from 1982 to 1994. Eur Heart J 1997; 18: 1.073-1.080.
9. Maynard C, Weaver D, Litwin P, Martin J, Kudenchuk P, Dewhurst T et al. Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the Myocardial Infarction Triage and Intervention Project). Am J Cardiol 1993; 72: 877-882.
10. Echanove I, Cabadés A, Velasco JA, Pomar F, Valls F, Francés M et al. Características diferenciales y supervivencia del infarto agudo de miocardio en la mujer. Registro) de infartos agudos de miocardio de la ciudad de Valencia (RICVAL). Rev Esp Cardiol 1997; 50: 851-859.
11. Herlitz J, Hartford M, Karlson BW, Dellborg M, Källström G Karlsson T. One-year mortality after acute myocardial infarction prior to and after the implementation of a widdespread use of thrombolysis and aspirin. Cardiology 1998; 89: 216-221.
12. Cabadés A, Marrugat J, Arós F. López-Bescós L, Pereferrer D, De los Reyes M et al. Buses para un registro hospitalario de infartos agudos tie miocardio en España. El estudio PRIAMHO. Rev Esp Cardiol 1996; 49: 393-404.
13. Vaur L, Danchin N, Genes N, Renault N, Etienn S. Ferrieres J et al. Caractéristiques des patients hospitalisés en France pour infartus du myocarde en fonction du degré d'attente de leur fonction ventriculaire gauche. Arch Mal Coeur 1997; 90: 1.485-1.492.
14. Adams JN, Jamieson M, Rawles JM, Trent RJ, Jennings KP, Women and myocardial infarction: agism rather than sexim? Br Heart J 1995; 73: 87-91.
15. Maheu B, Mansourati J, Guillo P, Larlet JM, Salaun G, Blanc JJ et al. Mortalité et morbidité a la phase aigue de l'infarctus du myocarde. Arch Mal Coeur 1996; 89; 187-192.
16. Cabadés A, Valls F, Echanove I, Francés M, Sanjuan R, Calabuig J et al. Estudio RICVAL. El infarto de miocardio en la ciudad de Valencia. Datos de 1.124 pacientes en los primeros 12 meses del Registro (diciembre de 1993-noviembre de 1994). Rev Esp Cardiol 1997; 50: 383-396.
17. McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR, Blackburn H et al. Recent trends in acute coronary heart disease, mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med 1996; 334: 884-890.
18. Rosamond WD, Chambless LLE, Folson AR, Cooper LS, Conwill DE, Clegg L et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339: 861-867.
19. Echanove I. Estudio de supervivencia al infarto de miocardio en los pacientes ingresados en la unidad coronaria del Hospital General de Valencia. Resúmenes de tesis doctorales 10.11. Universitat de Valencia: Serveis de Publications, 1988; 918.
20. Sala J, Marrugat J, Masiá R, Porta M and the REGICOR Investigators. Improvement in survival after myocardial infarction between 1978-75 and 1986-88 in the REGICOR study. Eur Heart J 1995; 16: 779-784.
21. Abbud ZA, Shindler DM, Wilson AC, Kostis JB, for the Myocardial Infarction Data Acquisition System Study Group. Effect of diabetes mellitus on short and long term mortality rates of patients with acute myocardial infarction: a statewide study. Am Heart J 1995; 130: 51-58.
22. Sanz G, Castañer A, Betriu A, Magriñá J, Roig E, Paré J et al. Determinants of prognosis in survivors of myocardial infarction. A prospective clinical angiographic study. N Engl J Med 1982; 306: 1.065-1.070.
23. Rouleau L, Talajic M, Sussex B, Potwin L, Warnica W, Davies RF et al. Myocardial Infarction in 1990s. Their risk factors, stratification and survival in Canada: The Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol 1996; 27: 1.119-1.127.
24. Goldberg RJ, Gore JM, Alpert JS, Osganian V, De Groot J, Bade J et al. Cardiogenic shock after acute myocardial infarction, Incidence and Mortality from a Comunity-wide Perspective, 1975 to 1988. N Engl J Med 1991; 325: 1.117.
25. Kelly TL, Gilpin E, Ahnve S, Henning H, Ross J. Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J 1985; 110: 535-541.
26. Gómez MA, Laoros A, Karagounis A, Alien A, Anderson J, for the TEAM-2 Investigators. Effect of cigarrette smoking on coronary patency after thrombolytic therapy for myocardial infarction. Am J Cardiol 1993; 72: 273-278.
27. Barbash Gl, White HD, Modan M, Dfaz R, Hampton JR, Heikkila J et al. for the Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Circulation 1993; 87: 53-58.
28. ISIS 2 (Second International Study of Infart Survival) Collaborative Group. Randomised trial of intravenous stretokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction. Lancet 1988; 2: 349-360.
29. Cabadés A, Echanove I, Cebrián J, Cardona J, Vall F, Parra V y los investigadores del PRIMVAC. Características, manejo y pronóstico del paciente con infarto agudo de miocardio en la Comunidad Valencia en 1995: resultados del registro PRIMVAC (Proyecto de Registro de Infarto Agudo de Miocardio de Valencia, Alicante y Castellón). Rev Esp Cardiol 1999; 52: 123-133.
30. Hurliman C, Arveiler D, Romier-Borgnat, Montalvo O, Schaffer. Evaluation des célais de prise en charge de l'infarctus du myocarde. Résultats d'une enquête en Alsace. Arch Mal Coeur 1998; 91: 873-878.
31. Ottessen M, Kober L, Torp-Pedersen C, Trandolapril Cardiac Evaluation Study Group. Impact of patient delay on mortality among 6676 patients with acute myocardial infarction [resurnen]. Eur Heart J 1995; 16(Supl): 9.
32. Boersma E, Maas ACP, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour Lancet 1996; 348: 771-775.